Redefining copy number variation and single-nucleotide polymorphism counting via novel concepts based on recent PCR...

Area of Science:

• Genetics
• Molecular Biology
• Bioinformatics

Background:

• Human genes exhibit significant copy number variations (CNVs) and single-nucleotide polymorphisms (SNPs), influencing gene expression, regulation, and disease susceptibility.
• Existing methods often struggle to detect CNVs and SNPs simultaneously, necessitating separate analyses and limiting comprehensive genetic profiling.
• The coexistence of CNVs and SNPs in genomic regions can amplify their impact, highlighting the need for integrated detection strategies.

Purpose of the Study:

• To develop and validate a novel, single quantitative polymerase chain reaction (qPCR) method for the simultaneous detection of CNVs and SNPs.
• To assess the time, cost-effectiveness, and accuracy improvements offered by this new integrated approach.
• To evaluate the method's performance in determining genetic status and allele frequencies in a specific population.

Main Methods:

• Combined primers designed using the STexS method with probes from the STexS II method for a single qPCR assay.
• Applied the novel method to detect CNVs and SNPs in the CYP2A6 and CYP2A7 genes.
• Validated the method by analyzing 100 human genomic DNA samples from an East Asian population and comparing results with NIH database data.

Main Results:

• Successfully detected both CNVs and SNPs in CYP2A6 and CYP2A7 genes using a single qPCR reaction.
• The new method demonstrated significant improvements in time efficiency, cost-effectiveness, and accuracy compared to separate detection methods.
• Allele frequency results for the CYP2A6 -48T > G SNP in the East Asian population were highly congruent with existing database values.

Conclusions:

• The developed method offers a robust and efficient solution for simultaneous CNV and SNP detection.
• This novel approach has the potential to redefine genetic profiling, enabling more accurate prediction of genetic characteristics.
• The findings support the advancement of personalized medicine through precise identification of individualized treatments based on comprehensive genetic status.